ATLASATLAS fair value
ATLAS has no fair value for this stock today.
BB Biotech (BION.SW)
BB Biotech stock price today, ATLAS forecast and fair value
Healthcare · Biotechnology · SIX Swiss Exchange · Switzerland
CHF 50.30▲ +1.82%
Prices as of Oct 27, 2026 · CHF
Chance of rising in 1 month
53%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on BB Biotech in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On BB Biotech
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives BB Biotech a 53% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between CHF 48.52 and CHF 52.52; in 9 out of 10, between CHF 45.23 and CHF 56.35. Estimated annual volatility is 23%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- CHF 2.7B
- Market cap (USD)
- $3.3B
- P/E ratio
- 2.5
- 52-week high
- CHF 57.00
- 52-week low
- CHF 40.05
- Revenue (12 months)
- CHF 1.1B
- Operating margin
- 97.7%
- Net margin
- 127.3%
- Beta
- 0.67
What this means
ATLAS does not publish a fair value for BION.SW right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks BION.SW has traded between CHF 40.05 and CHF 57.00. Today it is 11.8% below that high and 26% above its low.
On the business: net margin is 127.3%; it trades at 2.5 times earnings.
Its beta is 0.67: it tends to move less than the market.
About the company
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology.
Want to see everything about BB Biotech?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does BB Biotech do?
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology.
What is the chance BION.SW goes up next month?
53%: close to a coin flip. In half of the simulated outcomes, BION.SW ends the month between CHF 48.52 and CHF 52.52.
How big is BB Biotech and what is its P/E ratio?
BB Biotech's market capitalization is CHF 2.7B. Its price-to-earnings (P/E) ratio is 2.5: you pay CHF 2.51 for each CHF 1.00 of yearly earnings.
How volatile is BION.SW?
ATLAS estimates annual volatility at 23%. In a typical month, half of the outcomes end between CHF 48.52 and CHF 52.52.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer